2888. Safety and Immunogenicity of an Adjuvanted Chikungunya Virus (CHIKV) Virus-like Particle (VLP) Based Vaccine in Two Pivotal Phase 3 Trials, ≥12 Years of Age

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC10677554 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature